Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.60 |
| ▸ | NPC1 | O15118 | 5/20 | 0.60 |
| ▸ | RAB9A | P51151 | 5/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.60 |
| ▸ | TP53 | P04637 | 3/20 | 0.60 |
| ▸ | PKM | P14618 | 3/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.60 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.60 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.60 |
| ▸ | MASP2 | O00187 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 2/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | POLB | P06746 | 3/20 | 0.50 |
| ▸ | IDO1 | P14902 | 1/20 | 0.50 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL28759430 | 0.98 | ALDH1A1 (0.58) | ALDH1A1NPC1RAB9AKDM4ETP53 | |
| SCHEMBL30561047 | 0.75 | NPC1 (1.00) | ALDH1A1NPC1RAB9AKDM4ETP53 | |
| SCHEMBL30634854 | 0.75 | NPC1 (1.00) | ALDH1A1NPC1RAB9AKDM4ETP53 | |
| SCHEMBL172216 | 0.75 | NPC1 (1.00) | ALDH1A1NPC1RAB9AKDM4ETP53 | |
| SCHEMBL29034384 | 0.73 | ALDH1A1 (0.62) | ALDH1A1NPC1RAB9AKDM4ETP53 | |
| Water SCHEMBL9817804 | 0.73 | NPC1 (0.95) | ALDH1A1NPC1RAB9AKDM4ETP53 | |
| SCHEMBL16585836 | 0.73 | NPC1 (0.60) | ALDH1A1NPC1RAB9AKDM4ETP53 | |
| SCHEMBL5924627 | 0.71 | ALDH1A1 (0.60) | ALDH1A1NPC1RAB9AKDM4ETP53 | |
| SCHEMBL460600 | 0.71 | ALDH1A1 (0.61) | ALDH1A1NPC1RAB9AKDM4ETP53 | |
| SCHEMBL277761 | 0.71 | ALDH1A1 (0.60) | ALDH1A1NPC1RAB9AKDM4ETP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117567519-A | Benzimidazole phosphine derivative ionic platinum (II) complex with excellent red light emission and preparation method thereof | 濮阳职业技术学院 | 2024-02-20 | — | — | CN | claimed |
| CN-117567518-A | Efficient yellow light emitting ionic platinum complex based on benzimidazole phosphine ligand and preparation method thereof | 濮阳职业技术学院 | 2024-02-20 | — | — | CN | claimed |
| CN-114591365-A | Light-emitting copper compound based on benzimidazole phosphine oxide ligand and preparation method and application thereof | 郑州大学 | 2022-06-07 | — | — | CN | claimed |
| CN-110330527-B | Mononuclear copper complex with fluorescence property and preparation method thereof | 洛阳理工学院 | 2022-03-29 | — | — | CN | claimed |
| CN-113292607-B | Ionic luminescent platinum complex based on benzimidazole phosphine ligand and preparation method thereof | 郑州大学 | 2022-02-18 | — | — | CN | claimed |
| CN-113292607-A | Ionic luminescent platinum complex based on benzimidazole phosphine ligand and preparation method thereof | 郑州大学 | 2021-08-24 | — | — | CN | claimed |
| CN-110372733-A | Organic copper complex of a kind of metal with fluorescence property and preparation method thereof | 郑州大学 | 2019-10-25 | — | — | CN | claimed |
| CN-110330527-A | A kind of mononuclear copper complex and preparation method thereof with fluorescence property | 洛阳理工学院 | 2019-10-15 | — | — | CN | claimed |
| CN-117567518-A | Efficient yellow light emitting ionic platinum complex based on benzimidazole phosphine ligand and preparation method thereof | 濮阳职业技术学院 | 2024-02-20 | — | — | CN | disclosed |
| CN-117567518-A | Efficient yellow light emitting ionic platinum complex based on benzimidazole phosphine ligand and preparation method thereof | 濮阳职业技术学院 | 2024-02-20 | — | — | CN | disclosed |
| CN-117567519-A | Benzimidazole phosphine derivative ionic platinum (II) complex with excellent red light emission and preparation method thereof | 濮阳职业技术学院 | 2024-02-20 | — | — | CN | disclosed |
| CN-117567519-A | Benzimidazole phosphine derivative ionic platinum (II) complex with excellent red light emission and preparation method thereof | 濮阳职业技术学院 | 2024-02-20 | — | — | CN | disclosed |
| CN-117567519-A | Benzimidazole phosphine derivative ionic platinum (II) complex with excellent red light emission and preparation method thereof | 濮阳职业技术学院 | 2024-02-20 | — | — | CN | disclosed |
| CN-117567518-A | Efficient yellow light emitting ionic platinum complex based on benzimidazole phosphine ligand and preparation method thereof | 濮阳职业技术学院 | 2024-02-20 | — | — | CN | disclosed |
| US-20120157404-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2012-06-21 | — | — | US | disclosed |
| US-8088368-B2 | Antiviral compounds | GILEAD SCIENCES, INC. (US) | 2012-01-03 | — | — | US | disclosed |
| US-8088368-B2 | Antiviral compounds | GILEAD SCIENCES, INC. (US) | 2012-01-03 | — | — | US | disclosed |
| US-20100310512-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2010-12-09 | — | — | US | disclosed |
| US-20100310512-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2010-12-09 | — | — | US | disclosed |
| WO-2010132601-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2010-11-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120157404-A1 | ANTIVIRAL COMPOUNDS | MAVS, EIF2AK2, ZC3HAV1 | ALDH1A1 3957/4885NPC1 516/4885RAB9A 1694/4885 |
| US-20100310512-A1 | ANTIVIRAL COMPOUNDS | MAVS, EIF2AK2, ZC3HAV1 | ALDH1A1 3957/4885NPC1 516/4885RAB9A 1694/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.